DEA Required 8-hour Training for Opioid Prescribing and Pain Management for Dental Professionals - Zoom Webinar

The Medication Assisted Treatment Education (MATE) Act requires dental practitioners to meet specific training requirements tied to their initial or renewal DEA registration. Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form—regardless of whether a registrant is completing their initial registration application or renewing their registration—affirming that they have met the new training requirement.

This 8-hour course provides a comprehensive understanding of pain management in dental practice. The course will cover the importance of an evidence-based approach to patient management rather than a one size fits all strategy. Participants will learn about the role of opiates and alternatives in pain management, the legal and administrative issues with opiate prescribing, and plans to improve the safety of opiate use. This course contains assignments that must be completed before the webinar. DEA MATE Act

Course Type:

Register for Upcoming Sessions

June 9, 2023 8:00 am - June 9, 2023 3:45 pm

All times for all events are in local Central Time.

Zoom Webinar

Course Number: CF4071



Learn How To

Learning Objectives
  • Conduct and in-depth analysis of the current state of the opioid crisis in the United States, including its causes, impact, and relevant statistics
  • Effectively manage pain and optimize opioid prescribing practices specifically for pediatric patients
  • Evaluate pain management prescribing practices, taking into account the potential interactions and considerations with patients' other medications
  • Develop a comprehensive communications and referral system to address the needs of patients at risk of opioid use disorder, promoting early intervention and appropriate support
Course Overview
  • Substance use disorders
  • How is SUD currently defined?
  • Current statistics of SUD in the US
  • The top four substances of misuse in the US and how they may impact healthcare-related procedures and oral surgeries
  • Special considerations of patients with opioid use disorder
  • Understanding Buprenorphine
  • Special considerationsagreements when prescribing opioids.
  • Communication with patients and medical specialists regarding pain management
Identification and Management of Opioid and Substance Use Disorders in Pediatric Patients
  • Describe alcohol and drug use in early adolescence with progression to substance and opioid use disorders in late adolescence
  • Discuss the neurocognitive effects of addictive substances on the developing adolescent brain
  • Discuss patterns, trends, epidemiology, and contributing factors to opioid and other substance use/abuse among the child and adolescent population
  • Highlight similarities and differences, and discuss challenges of adolescents with co-occurring substance use and psychiatric disorders
  • Discuss how your team can identify and manage substance use and withdrawal syndrome behaviors in patients
  • Recognize and deliver safe dental and medically-related procedures for children and adolescents who are actively using alcohol and/or other drugs
  • Deliver safe care to children and adolescents currently receiving treatment for substance and opioid use disorders
  • Develop strategies for brief interventions, referrals, and resources for children, adolescents, parents, and caregivers
Mixing Common Prescriptions with Pain Management Medication: Insights from Your Local Pharmacist
  • Identify the ten most prescribed medications in adults and pediatrics
  • Recognize common oral and overall health associated with certain disease states
  • Discuss the ten most prescribed medications and what types of pain management medications are most effective
  • Recognize complications that prescribed medications can cause regarding oral and overall health
  • Identify limitations various federal mandates have on clinicians' medication prescribing
  • Understand the role of a clinical pharmacist in improving oral and overall health
  • Develop a cheat sheet with the right pain medication choices for patients with specific disease states
What Happens After You Identify and Refer Patients with Opioid and Other Substance Abuse Disorders?
  • Evaluate best practices in referral by analyzing case studies
  • Implement screening tools, such as the Opioid Risk Tool (ORT) or the Screener and Opioid Assessment for Patients with Pain (SOAPP), to identify potential cases of opioid abuse
  • Recognize signs of opioid abuse, including changes in behavior or mood, frequent requests for early refills or lost prescriptions, and evidence of drug-seeking behavior
  • Utilize prescription drug monitoring programs (PDMPs) to track patients' prescription histories and identify potential cases of opioid abuse or diversion
  • Refer patients with suspected addiction to specialists, such as psychiatrists, addiction medicine physicians, or substance abuse counselors, for evaluation and treatment
  • Implement medication-assisted treatment (MAT) for patients with substance abuse disorders
  • Identify how teens, young adults, adults, and seniors with substance abuse disorders may present in the dental clinic
  • Evaluate the prevalence of substance abuse disorders among LGBTQ+ patients
  • Compare and contrast substance abuse trends in urban versus rural areas
  • Provide educational resources for providers, patients, families, and caregivers related to opioid abuse and addiction
  • Assess what happens after a referral and identify what providers should know

​​​​Training Methods

Illustrated lectures, case studies, and discussion

Steps to Complete the Required Training

  1. Complete reading assignments (approximately 1.25 hours)
  2. Attest to the completion of the reading assignment
  3. Attend and complete the June 9, 2023, Zoom session
Step One – Complete the Reading Assignments

A total of 1.25 hours of readings must be completed prior to the webinar.

You may select from the following choices, or you may select other studies, reference materials, or web sites if you prefer. The National Center for Drug Abuse Statistics is an optional resource.

Step Two – Complete the Attestation Form

When you have completed the required readings, please complete the attestation form. This step must be completed before the Zoom webinar.

Step Three – Zoom Webinar, June 9, 2023

Attend all 6.75-hours of the live Zoom course.

Office of Interprofessional Continuing Professional Education
Jointly Accredited Provider with commendation

In support of improving patient care, this activity is being planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD) and the University of Minnesota School of Dentistry.

The National Center OICPD is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program, and the Athletic Training Board of Certification, Inc. (BOC) to provide continuing education for the healthcare team. 

The National Center OICPD will award ACCME AMA PRA Category 1 CreditsTM, ANCC nursing contact hours, ACPE contact hours (CEUs) for pharmacists and pharmacy technicians, ASWB continuing education credits, AT BOC Category A hours to attendees of this program. This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.